Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (odpre novo okno)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Vir‎: Cancer 2013;119(21):3784-7.

Indeksirano‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (odpre novo okno)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (odpre novo okno)

Chakrabarti S, Varma S, Singh S, Kumari S

Vir‎: Eur J Haematol 1998;60(5):313-4.

Indeksirano‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (odpre novo okno)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (odpre novo okno)

Delaney M, Matthews DC, Gernsheimer TB

Vir‎: Pediatr Blood Cancer 2017;64(12):e26641.

Indeksirano‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (odpre novo okno)

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. (odpre novo okno)

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH, Elmore JM

Vir‎: J Urol 2010;184(3):1152-7.

Indeksirano‎: PubMed 20650477

DOI‎: 10.1016/j.juro.2010.05.020

https://www.ncbi.nlm.nih.gov/pubmed/20650477 (odpre novo okno)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (odpre novo okno)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Vir‎: Leuk Lymphoma 1995;19(1-2):141-4.

Indeksirano‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (odpre novo okno)

Pediatric off-label use of recombinant factor VIIa. (odpre novo okno)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Vir‎: Pediatrics 2009;123(3):1066-72.

Indeksirano‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (odpre novo okno)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (odpre novo okno)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Vir‎: Indian J Pediatr 2011;78(8):961-8.

Indeksirano‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (odpre novo okno)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (odpre novo okno)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Vir‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Indeksirano‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (odpre novo okno)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (odpre novo okno)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Vir‎: Pediatr Blood Cancer 2016;63(10):1822-8.

Indeksirano‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (odpre novo okno)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (odpre novo okno)

Das P, Carcao M, Hitzler J

Vir‎: Pediatr Blood Cancer 2006;47(2):206-9.

Indeksirano‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (odpre novo okno)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (odpre novo okno)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Vir‎: Pediatr Blood Cancer 2008;50(5):1013-7.

Indeksirano‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (odpre novo okno)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (odpre novo okno)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Vir‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

Indeksirano‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (odpre novo okno)

Off-label use of recombinant factor VIIa in pediatric patients. (odpre novo okno)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Vir‎: Pediatrics 2012;129(6):e1533-40.

Indeksirano‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (odpre novo okno)

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). (odpre novo okno)

Neufeld EJ, Saxena K, Kessler CM, Cooper DL; HTRS Investigators

Vir‎: Pediatr Blood Cancer 2013;60(7):1178-83.

Indeksirano‎: PubMed 23335449

DOI‎: 10.1002/pbc.24472

https://www.ncbi.nlm.nih.gov/pubmed/23335449 (odpre novo okno)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (odpre novo okno)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Vir‎: Med Oncol 2010;27(1):16-9.

Indeksirano‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (odpre novo okno)

Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. (odpre novo okno)

Ucar C, Caliskan U

Vir‎: Pediatr Hematol Oncol 2006;23(4):339-45.

Indeksirano‎: PubMed 16621776

DOI‎: 10.1080/08880010600631987

https://www.ncbi.nlm.nih.gov/pubmed/16621776 (odpre novo okno)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (odpre novo okno)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Vir‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indeksirano‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (odpre novo okno)

The use of DDAVP in children with bleeding disorders. (odpre novo okno)

Ben-Ami T, Revel-Vilk S

Vir‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

Indeksirano‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (odpre novo okno)

Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). (odpre novo okno)

Kobrinsky NL, Tulloch H

Vir‎: J Pediatr 1988;112(6):993-6.

Indeksirano‎: PubMed 3373409

DOI‎: 10.1016/s0022-3476(88)80234-8

https://www.ncbi.nlm.nih.gov/pubmed/3373409 (odpre novo okno)

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (odpre novo okno)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Vir‎: J Pediatr Surg 2013;48(3):689-94.

Indeksirano‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (odpre novo okno)